Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

AIM: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). PATIENTS & METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liang Yen, Ji, Matthew S, Nguyen, Nhung T, Chow, Frances E, Molaie, Donna M, Pianka, Sean T, Green, Richard M, Liau, Linda M, Ellingson, Benjamin M, Nghiemphu, Phioanh L, Cloughesy, Timothy F, Lai, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713025/
https://www.ncbi.nlm.nih.gov/pubmed/31293169
http://dx.doi.org/10.2217/cns-2019-0007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713025/
https://www.ncbi.nlm.nih.gov/pubmed/31293169
http://dx.doi.org/10.2217/cns-2019-0007

Ejemplares similares